Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Austar LifesciencesAULSF 40 Graham Number is $0.20 as of Dec. 2025, which is 95% below its 10-year median of 4.26. GuruFocus rates AULSF with a GF Score™ of 40/100 and a GF Value™ of $0.08 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 404 Medical Devices & Instruments companies, Austar Lifesciences ranks better than 97.77% on this metric.
Graham Number is a figure that measures a stock's fundamental value by taking into account the company's earnings per share and book value per share. The Graham number is the upper bound of the price range that a defensive investor should pay for the stock. According to the theory, any stock price below the Graham number is considered undervalued, and thus worth investing in.
As of today (2026-08-15), the stock price of Austar Lifesciences is $0.02. Austar Lifesciences's graham number for the quarter that ended in Dec. 2025 was $0.20. Therefore, Austar Lifesciences's Price to Graham Number ratio for today is 0.10.
The historical rank and industry rank for Austar Lifesciences's Graham Number or its related term are showing as below:
AULSF'
s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.45 Med: 4.26 Max: 14.89
Current: 0.5
During the past 13 years, the highest Price to Graham Number ratio of Austar Lifesciences was 14.89. The lowest was 0.45. And the median was 4.26.
AULSF's Price-to-Graham-Number is ranked better than 97.77% of 404
companies
in the Medical Devices & Instruments industry
Industry Median: 1.9
vs AULSF: 0.50
Graham Number is a combination of asset valuation and earnings power valuation. It is a very conservative way of valuing a stock.
Austar Lifesciences (OTCPK:AULSF) Graham Number Explanation
Ben Graham actually did not publish a formula like this. But he wrote in The Intelligent Investor (1948 version) regarding to the criteria for purchases:
Current price should not be more than 15 times average earnings of the past three years.
Current price should not be more than 1.5 times the book value last reported. However, a multiplier of earnings below 15 could justify a correspondingly higher multiplier of assets. As a rule of thumb we suggest that the product of the multiplier times the ratio of price to book value should not exceed 22.5. (This figure corresponds to 15 times earnings and 1.5 times book value. It would admit an issue selling at only 9 times earnings and 2.5 times asset value, etc.)
Unlike valuation methods such as DCF or Discounted Earnings, the Graham number does not take growth into the valuation. Unlike the valuation methods based on book value alone, it takes into account the earnings power. Therefore, the Graham Number is a combination of asset valuation and earnings power valuation.
In general, the Graham number is a very conservative way of valuing a stock. It cannot be applied to companies with negative book values.
Austar Lifesciences's Price to Graham number Ratio for today is calculated as
Price to Graham number
=
Share Price (Today)
/
Graham number (Q: Dec. 2025 )
=
0.02
/
0.20
=
0.10
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Please keep these in mind:
1. Graham Number does not take growth into account. Therefore it underestimates the values of the companies that have good earnings growth. We feel that if the earnings per share grows more than 10% a year, Graham Number underestimates the value.
2. Graham Number punishes the companies that have temporarily low earnings. Therefore, an average of earnings makes more sense in the calculation of Graham Number.
3. Graham Numbers underestimates companies that are light with book.
Austar Lifesciences Graham Number Related Terms
Austar Lifesciences Graham Number Historical Data
* Premium members only.
The historical data trend for Austar Lifesciences's Graham Number can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Austar Lifesciences's Price-to-Graham-Number, along with its competitors' market caps and Price-to-Graham-Number data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Austar Lifesciences Price-to-Graham-Number vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Austar Lifesciences's Price-to-Graham-Number distribution charts can be found below:
* The bar in red indicates where Austar Lifesciences's Price-to-Graham-Number falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Austar Lifesciences (AULSF) has a Graham Number of $0.20 as of Dec. 2025. The Graham Number values a company based on its per-share earnings and book value. View historical data on Austar Lifesciences and its competitors. This is 95% below median its historical median of 4.26. Over the past decade, Austar Lifesciences' Graham Number has ranged from 0.45 to 14.89. According to the industry distribution chart, Austar Lifesciences ranks #9 out of 404 companies in the Medical Devices & Instruments industry, placing it in the top 2.2%.
Is Austar Lifesciences' Graham Number too high?
Austar Lifesciences' current Graham Number of $0.20 is 95% below median its 10-year median of 4.26. Over the past 10 years, this metric has ranged from a low of 0.45 to a high of 14.89. The Medical Devices & Instruments industry median Graham Number is 1.90. Austar Lifesciences' value of $0.20 is 89.5% below this industry median. Based on the distribution chart, Austar Lifesciences ranks #9 out of 404 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Austar Lifesciences has a GF Score™ of 40/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Austar Lifesciences' Graham Number compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Austar Lifesciences ranks #9 out of 404 companies for Graham Number. This places Austar Lifesciences in the top 2% of its industry — outperforming the majority of peers. The industry median Graham Number is 1.90. Austar Lifesciences' value of $0.20 is 89.5% below this benchmark. Historically, Austar Lifesciences' own Graham Number has ranged from 0.45 to 14.89 over the past decade. While the company's 10-year median is 4.26 vs. the industry median of 1.90, Austar Lifesciences has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Graham Number for a Medical Devices & Instruments company?
The median Graham Number among Medical Devices & Instruments companies is 1.90, based on 404 companies in the industry. Companies in the top quartile (top 25%) have a Graham Number significantly above this median, while those in the bottom quartile fall well below. However, Graham Number should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Austar Lifesciences's current Graham Number of $0.20 is 89.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Graham Number mean?
A high Graham Number can signal that a stock is expensive relative to its fundamentals. The Graham Number values a company based on its per-share earnings and book value. View historical data on Austar Lifesciences and its competitors. For the Medical Devices & Instruments industry, the median Graham Number is 1.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Austar Lifesciences's current Graham Number is $0.20, which is 95% below median its own 10-year median of 4.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Austar Lifesciences stock overvalued right now?
Based on GuruFocus' analysis, Austar Lifesciences (AULSF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.08, compared to a current price of $0.02 — trading 75% below its estimated fair value. The current Graham Number is $0.20, which is 95% below median its 10-year median of 4.26 and 89.5% below the Medical Devices & Instruments industry median of 1.90. Austar Lifesciences' overall GF Score™ is 40/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Graham Number calculated?
Graham Number is calculated from a company's financial statements. For Austar Lifesciences (AULSF), the current Graham Number is $0.20 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Austar Lifesciences (AULSF) Overvalued in 2026?
Based on GuruFocus' analysis, Austar Lifesciences stock appears to be undervalued.
The current stock price of $0.02 is trading 75% below its estimated GF Value™ of $0.08.
GuruFocus considers Austar Lifesciences to be Possible Value Trap.
Key valuation signals for AULSF:
Graham Number: $0.20 (95% below median its 10-year median of 4.26)
GF Value™: $0.08 vs. price of $0.02 (75% below fair value)
Industry Position: 89.5% below the Medical Devices & Instruments median (#9 of 404)
No single metric tells the full story. See the AULSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Austar Lifesciences Ltd is an investment holding company, and its subsidiaries are principally engaged in providing integrated engineering solutions to pharmaceutical manufacturers and research institutes, as well as manufacturing and distribution of pharmaceutical equipment and consumables in the PRC. Its products include Clean Utility Equipment & Chemical Pharmaceutical Preparation System and others. It has three business segment groups: Integrated Process and Packaging Equipment & Systems (IPS), which generates maximum revenue and combines the original business segments of Liquid and Bioprocess System and Powder and Solid System; Consulting, Digitalization, and Construction; and Life Science Equipment and Consumables. The Group generates maximum revenue from Mainland China.
40GF Score
Get the complete analysis for AULSF
Graham Number is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AULSF has been successfully added to your 
